Diamond Medical Weight Control and Wellness Center

Diamond Medical Weight Control and Wellness Center operates in Norco, California, delivering medical weight loss programs anchored by GLP-1 receptor agonist peptide therapy and comprehensive hormone optimization. The clinic structures its protocols around Semaglutide and Tirzepatide, two FDA-approved peptides that regulate appetite, slow gastric emptying, and improve insulin sensitivity. Patients receive individualized dosing schedules based on metabolic panel results, body composition analysis, and weight loss velocity, with protocols adjusted every four weeks to maintain efficacy while minimizing gastrointestinal side effects. The Norco facility combines in-person consultations with telehealth follow-ups for California residents, allowing patients to receive initial assessments and periodic check-ins at the clinic while managing routine monitoring remotely. This hybrid model accommodates working professionals in Riverside County and surrounding Inland Empire communities who require flexible scheduling without sacrificing clinical oversight.

The weight loss programs at Diamond Medical integrate Semaglutide and Tirzepatide with advanced hormone therapy to address metabolic dysfunction that often underlies weight gain. Providers evaluate thyroid function through comprehensive panels including Free T3, Reverse T3, and thyroid antibodies rather than relying solely on TSH screening. For patients with documented hormone deficiencies, the clinic prescribes bioidentical hormone replacement therapy alongside peptide protocols, recognizing that optimizing testosterone, estrogen, or thyroid hormones can enhance the metabolic response to GLP-1 agonists. Wellness injections—including lipotropic compounds, B-vitamin complexes, and amino acid formulations—supplement the core peptide therapy to support energy levels during caloric restriction and preserve lean muscle mass. Each program includes baseline and interval laboratory testing to track fasting glucose, hemoglobin A1c, lipid panels, and liver enzymes, ensuring that weight loss occurs without adverse metabolic consequences.

Diamond Medical's approach emphasizes the physiological mechanisms behind peptide-driven weight loss rather than relying on willpower-based dieting. Semaglutide and Tirzepatide mimic incretin hormones that signal satiety to the hypothalamus, reduce hepatic glucose production, and slow the rate at which food exits the stomach. Patients typically begin with low-dose subcutaneous injections administered weekly, with gradual titration over 16 to 20 weeks to therapeutic levels. The clinic provides injection training during the initial visit, teaching proper reconstitution techniques for peptide vials, subcutaneous injection site rotation, and refrigeration requirements. Providers monitor for common side effects including nausea, constipation, and injection site reactions, adjusting dosages or prescribing adjunctive medications when necessary. For patients who plateau after initial weight loss, the clinic evaluates metabolic adaptation through resting metabolic rate testing and adjusts caloric targets or considers transitioning between Semaglutide and Tirzepatide based on individual receptor sensitivity.

Patients beginning treatment at Diamond Medical in Norco undergo a comprehensive intake process that includes medical history review, current medication assessment, and discussion of weight loss goals with realistic timelines. The clinic excludes candidates with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis, adhering to FDA contraindications for GLP-1 therapies. Initial visits include body composition analysis via bioelectrical impedance to establish baseline lean mass and fat mass percentages, allowing providers to track whether weight loss derives primarily from adipose tissue rather than muscle. Patients receive structured nutritional guidance focused on adequate protein intake—typically 0.8 to 1.0 grams per pound of ideal body weight—to preserve muscle during caloric deficit. The clinic schedules follow-up appointments every four weeks during the active weight loss phase, with laboratory monitoring at 12-week intervals to assess metabolic markers and adjust hormone therapy as body composition changes.

Diamond Medical Weight Control and Wellness Center serves patients throughout Riverside County, with the Norco location providing convenient access for residents of Corona, Eastvale, Jurupa Valley, and Mira Loma. The hybrid consultation model allows California patients to complete initial assessments in person while managing ongoing care through HIPAA-compliant telehealth platforms, reducing travel requirements for routine check-ins and prescription adjustments. The clinic maintains a 5.0-star rating across patient reviews, reflecting consistent execution of peptide protocols and responsive clinical support. For individuals who have struggled with traditional calorie-restriction diets or experienced weight regain after previous attempts, the combination of Semaglutide or Tirzepatide with hormone optimization and metabolic monitoring offers a physiologically grounded alternative that addresses the hormonal and neurological factors driving appetite and fat storage.